1. Home
  2. TCRT vs CELZ Comparison

TCRT vs CELZ Comparison

Compare TCRT & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

HOLD

Current Price

$2.45

Market Cap

6.1M

Sector

Health Care

ML Signal

HOLD

Logo Creative Medical Technology Holdings Inc.

CELZ

Creative Medical Technology Holdings Inc.

HOLD

Current Price

$1.94

Market Cap

7.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCRT
CELZ
Founded
1998
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
7.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TCRT
CELZ
Price
$2.45
$1.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.3K
136.2K
Earning Date
11-14-2025
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,000.00
$6,000.00
Revenue This Year
$5,680,500.00
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$1.50
52 Week High
$6.20
$6.90

Technical Indicators

Market Signals
Indicator
TCRT
CELZ
Relative Strength Index (RSI) 33.42 43.07
Support Level $2.60 $1.95
Resistance Level $3.02 $2.12
Average True Range (ATR) 0.17 0.16
MACD -0.02 0.01
Stochastic Oscillator 10.43 28.40

Price Performance

Historical Comparison
TCRT
CELZ

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Share on Social Networks: